MYP_128071
Buserelin
Anticancer
Hormonal / Endocrine
▸
Hormone peptide
not Standard
9 amino acids
-
contains X representing unresolved or non-standard residue
XHWSYXLRP
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available: incomplete physicochemical profile.
- Molecular Weight
- Not available
- Isoelectric Point (pI)
- Not available
- Net Charge (pH 7.0)
- Not available
- GRAVY Index
- Not available
- Boman Index
- Not available
- Instability Index
- Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Amino Acid Composition
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0245075
REVIEWED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Enzyme
32630
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Anticancer
Hormone replacement
CHO
50-80 minutes by IV dose, 80 mins. By SC dose, 1-2 hrs by Intranasal dose
RECORD: Rec_0257843
REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Hydrazide
Non-standard residues/X at 1, 6
Bio-Activity Profile
GnRH agonist
Endocrine
Anticancer
Human GnRH receptor
Clinical/Human: 4-5 h
RECORD: Rec_0311550
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
GnRH analog
32630
Structure & Mods
linear synthetic GnRH analog [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
Ethylamide
D-Ser(tBu) at position 6
Bio-Activity Profile
Endocrine
GnRH agonist
Hormone therapy
50-80 minby IV dose, 80 min. By SC dose, 1-2 h by Intranasal dose
RECORD: Rec_0329711
REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
N-ethylamide
Non-standard residues/X at 1, 6
Bio-Activity Profile
GnRH agonist
Endocrine
Human GnRH receptor
Clinical/Human: 3.92 ± 1.01 hr